Literature DB >> 1592392

Immunohistochemical study of epidermal growth factor and transforming growth factor-beta in the penetrating type of early gastric cancer.

D Hirayama1, T Fujimori, K Satonaka, T Nakamura, S Kitazawa, M Horio, S Maeda, K Nagasako.   

Abstract

We report that the penetrating type of early gastric cancer (PEN) is a specific type of early gastric cancer and that the poorly differentiated PEN type could be considered an initial lesion of linitis plastica-type cancer. We performed an immunohistochemical study to clarify the role of growth factors (epidermal growth factor [EGF] and transforming growth factor-beta [TGF-beta]) in the PEN type of early gastric cancer. The results indicated that the PEN type of early gastric cancer has a high growth capacity. Moreover, it was suggested that EGF was involved in its specific infiltrative growth and that both EGF and TGF-beta were involved in its specific scirrhous growth. From these findings, it was assumed that the immunohistochemical staining of EGF and TGF-beta in endoscopic biopsy specimens was useful for the diagnosis of the PEN type of gastric cancer and also for the diagnosis of the initial lesion of linitis plastica-type gastric cancer.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1592392     DOI: 10.1016/0046-8177(92)90325-w

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  15 in total

Review 1.  Molecular biology and gastric carcinoma.

Authors:  P A Wright; G T Williams
Journal:  Gut       Date:  1993-02       Impact factor: 23.059

2.  Immunohistochemical expression of TGF-beta1, p21WAF1, p53, Ki67, and angiogenesis in gastric carcinomas: a clinicopathologic study.

Authors:  Vassiliki Zolota; Anna Batistatou; Athanassios C Tsamandas; George Iliopoulos; Chrisoula D Scopa; Dionysis S Bonikos
Journal:  Int J Gastrointest Cancer       Date:  2002

3.  Transforming growth factor-beta signaling promotes hepatocarcinogenesis induced by p53 loss.

Authors:  Shelli M Morris; Ji Yeon Baek; Amanda Koszarek; Samornmas Kanngurn; Sue E Knoblaugh; William M Grady
Journal:  Hepatology       Date:  2011-12-06       Impact factor: 17.425

Review 4.  Pathologic prognostic factors for gastrointestinal cancer.

Authors:  T Ismail; M T Hallissey; J W Fielding
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

Review 5.  Current research in perineural invasion of cholangiocarcinoma.

Authors:  Fang-Zhen Shen; Bing-Yuan Zhang; Yu-Jie Feng; Zhuo-Xia Jia; Bing An; Chang-Chang Liu; Xi-Yun Deng; Anil D Kulkarni; Yun Lu
Journal:  J Exp Clin Cancer Res       Date:  2010-03-10

6.  Presence of two signaling TGF-beta receptors in human pancreatic cancer correlates with advanced tumor stage.

Authors:  Z Lu; H Friess; H U Graber; X Guo; M Schilling; A Zimmermann; M Korc; M W Büchler
Journal:  Dig Dis Sci       Date:  1997-10       Impact factor: 3.199

7.  Relation of neuroendocrine cells to transforming growth factor-alpha and epidermal growth factor receptor expression in gastric adenocarcinomas: prognostic implications.

Authors:  Cigdem Celikel; Funda Eren; Bahadir Gulluoglu; Nural Bekiroglu; Serdar Turhal
Journal:  Pathol Oncol Res       Date:  2007-10-07       Impact factor: 3.201

8.  Comparative clinicopathological and immunohistochemical study of ras and p53 in flat and polypoid type colorectal tumours.

Authors:  M Yukawa; T Fujimori; S Maeda; M Tabuchi; K Nagasako
Journal:  Gut       Date:  1994-09       Impact factor: 23.059

9.  Transforming growth factor-beta receptors and mannose 6-phosphate/insulin-like growth factor-II receptor expression in human hepatocellular carcinoma.

Authors:  S R Sue; R S Chari; F M Kong; J J Mills; R L Fine; R L Jirtle; W C Meyers
Journal:  Ann Surg       Date:  1995-08       Impact factor: 12.969

10.  Transforming growth factor beta 1 secreted from scirrhous gastric cancer cells is associated with excess collagen deposition in the tissue.

Authors:  K Mahara; J Kato; T Terui; R Takimoto; M Horimoto; T Murakami; Y Mogi; N Watanabe; Y Kohgo; Y Niitsu
Journal:  Br J Cancer       Date:  1994-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.